Alumis Announces Late-Breaker Oral Presentation of Phase 3 Data for Envudeucitinib in Moderate-to-Severe Plaque Psoriasis at 2026 American Academy of Dermatology Annual Meeting

Phase 3 data presentation highlighting results from the ONWARD1 and ONWARD2 clinical trials of envudeucitinib –– Phase 2 STRIDE e-poster ...

Arcutis to Present New Clinical Data in a Late-Breaking Podium Presentation and Scientific Posters at the 2026 American Academy of Dermatology Annual Meeting

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that it will present new ...
Kaleido Scope

CCTS Translational Science Symposium Poster Presentation

Are you ready to showcase your research and sharpen your communication skills? Join us for the upcoming 2025 CCTS Translational Science Symposium held on October 30th-October 31st. On October 30th, ...